Drug – bio-affecting and body treating compositions – Fermentate of unknown chemical structure
Reexamination Certificate
2005-02-08
2005-02-08
Naff, David M. (Department: 1651)
Drug, bio-affecting and body treating compositions
Fermentate of unknown chemical structure
C424S093430, C435S253500, C435S886000
Reexamination Certificate
active
06852317
ABSTRACT:
A novel antibiotic-producingStreptomycessp. is provided that exhibits antifungal activity only on certain specific plant pathogens. Also provided is a method of treating or protecting plants from fungal infections comprising applying an effective amount of an antibiotic-producingStreptomycessp. having all the identifying characteristics of NRRL Accession number B-30145. The invention also relates to fungicidal compositions comprising this novelStreptomycesstrain and the antibiotics and metabolites produced by this strain either alone, or in combination with other chemical and biological pesticides.
REFERENCES:
patent: 4107297 (1978-08-01), Omura et al.
patent: 5403584 (1995-04-01), Crawford et al.
patent: 5527526 (1996-06-01), Crawford
patent: 5641804 (1997-06-01), Breinholt et al.
patent: 0 408 811 (1991-01-01), None
patent: 63297398 (1988-05-01), None
patent: WO 9629874 (1996-10-01), None
patent: WO 9835017 (1998-08-01), None
Akasaki, K., et al., “Monazomycin, A New Antibiotic Produced by aStreptomyces,” The Journal of Antibiotics. Ser.A—XVI(3): 127-131 (1963).
Axelrood, P.E., et al., “Douglas-fir Root-Associated Microorganisms with Inhibitory Activity Towards Fungal Plant Pathogens and Human Bacterial Pathogens,”Can.J.Microbiol.—42:690-700 (1996).
Borges, M., et al., “An achaete-scute Homologue Essential for Neuroendocrine Differentiation in the Lung,”Nature—386:852-855 (1997).
Campos, G., et al. “Griseocarnin, an Antifungal Antibiotic Isolated fromStreptoverticillium Criseocameum(IA-7527),”Rev.Inst.Antibiot(Reclfe)—14:1-2(1974) Abstract.
Chamberlain, K., et al., “In vitro and in vivo Antagonism of Pathogenic Turfgrass Fungi byStreptomyces HygroscopicusStrains YCED9 an WYE53,”Journal of Industrial Microbiology and Biotechnology—23:641-646 (1999).
Claridge, C.A., et al., “New Mitomycin Analogs Produced by Directed Biosynthesis,”The Journal of Antibiotics—XXXIX(3): 437-446 (1986).
Komorl, T., et al., “Isolation of the Aromatic Heptaenic Antibiotics Trichomycin A-F by High-Performance Liquid Chromatography,”Journal of Chromatography—481:416-420 (1989).
Lechevalier, M.P., “Actinomycetes in Agriculture and Forestry,”Actinomycetes in Biotechnology—327-358 (1988).
Mitscher, L.A. et al., “The structure of neutramycin,” Experientia vol. 25, p. 12-13(1969).
Reddi, G.S. et al., “Antagonism of soil actinomycetes to some soil-borne plant pathogenic fungi,” Indian Phytopathol. vol. 24, pp. 649-657 (1971).
Rothrock, C.S., et al., “Role of antibiosis in antagonism ofStreptomyces hygroscopicusvar.geldanustoRhizoctonia solaniin soil,”Can. J. Microbiol.—vol. 30,—pp. 1440-1447 (1984).
Schwinn, et al., “Advances in Plant Pathology:Phytophthora infestans, The Cause Of Late Blight Of Potato,”Academic Press, San Diego, p. 244-265 (1991).
Yuan, W.M., et al., “Characterization ofStreptomyces LydicusWYEC 108 as a Potential Biocontrol Agent Against Fungal Root and Seed Rots,”Applied and Environmental Microbiology—61(8):3119-3128 (1995).
Lehman Lori Jo
Manker Denise Carol
Marrone Pamela Gail
McCoy Randy Jay
Orjala Jimmy Ensio
AgraQuest, Inc.
McDonough Holland & Allen PC
Naff David M.
Ware Deborah K.
LandOfFree
Metabolite from streptomyces strain NRRL accession No.... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Metabolite from streptomyces strain NRRL accession No...., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Metabolite from streptomyces strain NRRL accession No.... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3499184